Bone Biologics Corp Stock Price on April 5, 2024
| BBLGW Stock | USD 40.00 9.65 31.80% |
If you're considering investing in Bone Stock, it is important to understand the factors that can impact its price. As of today, the current price of Bone Biologics stands at 40.00, as last reported on the 16th of May 2024, with the highest price reaching 40.00 and the lowest price hitting 40.00 during the day. Bone Biologics is slightly risky given 3 months investment horizon. Bone Biologics Corp secures Sharpe Ratio (or Efficiency) of 0.26, which signifies that the company had a 0.26% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 4.71% are justified by taking the suggested risk. Use Bone Biologics Mean Deviation of 11.22, downside deviation of 17.46, and Risk Adjusted Performance of 0.1326 to evaluate company specific risk that cannot be diversified away.
Total Stockholder Equity is likely to climb to about 3.1 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 250 K in 2024. . At this time, Bone Biologics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to climb to 0.43 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.0004 in 2024. Bone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Bone |
Sharpe Ratio = 0.2618
| Best Portfolio | Best Equity | BBLGW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.98 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.71 actual daily | 93 93% of assets have lower returns |
Risk-Adjusted Return
| 0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average Bone Biologics is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bone Biologics by adding it to a well-diversified portfolio.
Book Value (1.19) | Shares Float 480.9 K | Shares Short Prior Month 1.2 K | Earnings Share (0.14) | Shares Short 631 |
Bone Biologics Main Headline on 5th of April 2024
Filed transaction by Bone Biologics Corp Director, 10 Percent Owner, Officer Chairman Of The Board. Grant, award or other acquisition pursuant to Rule 16b-3
Bone Biologics Valuation on April 5, 2024
It is possible to determine the worth of Bone Biologics on a given historical date. On April 5, 2024 Bone was worth 9.99 at the beginning of the trading date compared to the closed value of 9.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bone Biologics stock. Still, in general, we apply an absolute valuation method to find Bone Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bone Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bone Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 13.00 | 13.00 | 9.99 | 9.99 | 1,046 | |
04/05/2024 | 9.99 | 9.99 | 9.99 | 9.99 | 1,300 |
| 9.00 | 9.00 | 9.00 | 9.00 | 300.00 |
| Backtest Bone Biologics | | | Bone Biologics History | | | Bone Biologics Valuation | Previous | Next |
Bone Biologics Trading Date Momentum on April 5, 2024
| On April 08 2024 Bone Biologics Corp was traded for 9.00 at the closing time. The highest daily price throughout the period was 9.00 and the lowest price was 9.00 . The daily volume was 300. The net trading volume on 04/08/2024 added to the next day price reduction. The overall trading delta to closing price of the next trading day was 9.91% . The overall trading delta to current closing price is 90.19% . |
Bone Biologics Corp Fundamentals Correlations and Trends
By evaluating Bone Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bone financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bone Biologics Stock history
Bone Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bone Biologics Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bone Biologics stock prices may prove useful in developing a viable investing in Bone Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 263.1 K | 250 K |
Bone Biologics Stock Technical Analysis
Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bone Biologics Period Price Range
Low | April 5, 2024
| High |
9.99 | 9.99 |
Bone Biologics May 16, 2024 Market Strength
Market strength indicators help investors to evaluate how Bone Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bone Biologics shares will generate the highest return on investment. By undertsting and applying Bone Biologics stock market strength indicators, traders can identify Bone Biologics Corp entry and exit signals to maximize returns
Bone Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bone Biologics' price direction in advance. Along with the technical and fundamental analysis of Bone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1326 | |||
| Jensen Alpha | 3.66 | |||
| Total Risk Alpha | 1.19 | |||
| Sortino Ratio | 0.1955 | |||
| Treynor Ratio | (1.68) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Bone Biologics Corp information on this page should be used as a complementary analysis to other Bone Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Bone Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.14) | Return On Assets (0.96) | Return On Equity (2.02) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.